has documented efficacy as an off-label treatment of AL amyloidosis. It appears to be an alternative to the more traditional treatment with melphalan in people who are ill-suited for autologous stem cell transplant.

Graft-versus-host disease

Graft-versus-host disease (GVHD) is a major barrier for allogeneic stem cell transplant

1.Previous
3.Next